Company / SG&A Expense
Ensign Group SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$269.8M
FY2025
5-year range
$151.8M / $269.8M
FY2021-FY2025
Trend
+19.8%
vs FY2024
Sector context
#94 of 158
Health Care
What the data says
At $270M, Ensign Group's sg&a expense ranks #65 of 158 in the Health Care sector. Increased from $263M to $270M over the past 2 years.
Based on SEC 10-K filings.
$270M in FY2025 with a 5-year CAGR of +15.8%.
Increased from $263M to $270M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
#65 of 158 in Health CareTop 41% of 158This company $269.8M Sector average $175.9B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 19.8% year-over-year.
- Ranks #94 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $269.8M | +19.8% |
| FY2024 | $225.1M | -14.4% |
| FY2023 | $263.0M | +65.6% |
| FY2022 | $158.8M | +4.6% |
| FY2021 | $151.8M | +17.0% |
| FY2020 | $129.7M | +17.0% |
| FY2019 | $110.9M | +22.4% |
| FY2018 | $90.6M | +22.2% |
| FY2017 | $74.1M | +7.2% |
| FY2016 | $69.2M | +7.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026